Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2369

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis ; volume:18 ; number:1 ; day:7 ; month:6 ; year:2017 ; pages:1-12 ; date:12.2017
BMC nephrology ; 18, Heft 1 (7.6.2017), 1-12, 12.2017

Keyword: Urologische Chirurgie

Creator: Lazrak, Hind Harrak

Contributor: René, Émilie
Elftouh, Naoual
Leblanc, Martine
Lafrance, Jean-Philippe
SpringerLink (Online service)

DOI: 10.1186/s12882-017-0596-4

URN: urn:nbn:de:1111-201710184614

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lazrak, Hind Harrak
René, Émilie
Elftouh, Naoual
Leblanc, Martine
Lafrance, Jean-Philippe
SpringerLink (Online service)

Other Objects (12)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin

Use of low-molecular-weight heparin in severe paraquat poisoning: a case report

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy

Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Molecular Weight Distribution Studies on Heparin

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin

Use of low-molecular-weight heparin in severe paraquat poisoning: a case report

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy

Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Molecular Weight Distribution Studies on Heparin

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin

Use of low-molecular-weight heparin in severe paraquat poisoning: a case report

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy

Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Molecular Weight Distribution Studies on Heparin

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin

Use of low-molecular-weight heparin in severe paraquat poisoning: a case report

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy

Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Molecular Weight Distribution Studies on Heparin

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin

Use of low-molecular-weight heparin in severe paraquat poisoning: a case report

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy

Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Molecular Weight Distribution Studies on Heparin

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin

Use of low-molecular-weight heparin in severe paraquat poisoning: a case report

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Low-molecular-weight heparin-induced skin necrosis without platelet fall: a case report in pregnancy

Effects of Clopidogrel and Low-Molecular-Weight Heparin on Viability of Random Skin Flaps in Rats

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19

Molecular Weight Distribution Studies on Heparin

Related objects

Reset password